Signatur Biosciences

Thame, United Kingdom · Founded 2022 · Privately Held (backing)

Developer of a PCR testing platform designed to make precision diagnostics accessible to all. Signatur Biosciences is based in Thame, United Kingdom and was founded in 2022. Its last reported valuation was $7.1 million in Jan 2022. It has raised $7.5 million.

Last reported valuation
$7.1M
Oct 2026
Priced at
—
Total raised
$7.5M
Last round
—

Who backs Signatur Biosciences?

8 investors
InvestorType
Y CombinatorOther
Imperial Enterprise LabOther
NoshaqOther
Anjost InvestmentFamily office
PSR CryptoFamily office
Myelin VC—
Riceberg Ventures—
The Discovery Labs—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Signatur Biosciences investors

8 investors are on record for Signatur Biosciences, including Y Combinator, Imperial Enterprise Lab, Noshaq and Anjost Investment.

Private Market View
More of Signatur Biosciences with a free Private Market View account
  • ·Watch Signatur Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Signatur Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View